Is the use of HBMP effective in preventing thrombotic events in hospitalized oncology patients?
No direct evidence for the use of HBMP in preventing thrombotic events in hospitalized oncology patients was identified. Existing guidelines recommend LMWH and DOACs for VTE prevention, highlighting the need for further research to optimize thromboprophylactic strategies in this population.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24344236
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00